Results 211 to 220 of about 22,089 (224)

Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes

Autoimmunity Reviews, 2009
Martin J Richer, Marc S Horwitz
exaly  

The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3

Phytomedicine, 2009
Haibo Wang, Yuanyuan Ding, Siwang Wang   +2 more
exaly  

The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease

Vaccine, 2018
Hyun Ju In, Gyung Tae Chung, Young Ki Choi   +2 more
exaly  

Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice

Antiviral Research, 2017
Yan Zhi, Xiangchun Shen
exaly  

Coxsackievirus myocarditis.

Advances in internal medicine, 1992
N R, Rose, D A, Neumann, A, Herskowitz
openaire   +1 more source

Differential Macrophage Polarization in Male and Female BALB/c Mice Infected With Coxsackievirus B3 Defines Susceptibility to Viral Myocarditis

Circulation Research, 2009
Kang Li, Yan Yue, Sidong Xiong
exaly  

Developing a vaccine for type 1 diabetes by targeting coxsackievirus B

Expert Review of Vaccines, 2018
Heikki Hyoty, Mikael Knip
exaly  

Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection

Journal of the American Academy of Dermatology, 2013
Jason P Lott, W Allan Nix, M Steven Oberste   +2 more
exaly  

Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice

Antiviral Research, 2016
Chao Zhang, Ke Lan, Qingwei Liu
exaly  

Anti-coxsackievirus B3 activity of 2-amino-3-nitropyrazolo[1,5-a]pyrimidines and their analogs

Bioorganic and Medicinal Chemistry Letters, 2005
Vadim Makarov, Olga Riabova, Hans-Martin Dahse   +2 more
exaly